过去一年中添加的文章,按日期排序

POS1457-HPR 7-YEAR PERSISTENCE OF ANTI-TNF THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND IMPACT ON DISEASE ACTIVITY

P Santos-Moreno, P Rodríguez-Linares, W Rivero… - 2024 - ard.bmj.com
23 天前 - … anti-TNF drugs infliximab, etanercept and adalimumab on … in to account because
COVID-19 pandemic potential bias. … ), etanercept (n=64), or infliximab (n=63) during the 7-year …

Treatment of multisystem inflammatory syndrome in children

T Tong, YH Jin, M Wang, FQ Gong - World Journal of Pediatrics, 2024 - Springer
95 天前 - … , such as anakinra and infliximab, have been described for the management of
COVID-19-… A clinical study was conducted by Kaushik et al. among different care centers to …

COVID-19: Clinical Advances and Challenges

S Arora, L Palaiodimos - 2024 - mdpi.com
165 天前 - … This SI reprint comprehensively explores the ongoing COVID-19 pandemic, addressing
… health implications. This 30-article reprint reflects the breadth and depth of the medical